• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer.

作者信息

Buccheri G, Ferrigno D, Vola F

机构信息

Department of Thoracic Medicine, Antonio Carle Hospital of Chest Diseases, Cuneo, Italy.

出版信息

Lung Cancer. 1993 Oct;10(1-2):21-33. doi: 10.1016/0169-5002(93)90306-i.

DOI:10.1016/0169-5002(93)90306-i
PMID:8069601
Abstract

Multivariate models of survival have been established for both small cell and non-small cell lung cancers. So far, no study has focussed on squamous cell types. Previous demonstrations of the prognostic value of the tissue polypeptide antigen (TPA) and, partially, of the carcinoembryonic antigen (CEA) are based on univariate analyses of survival. These analyses do not account for the other prognostic factors. In the present study, we report the combined influence of various clinical and biological characteristics on the survival duration of 360 patients with a newly diagnosed squamous cell carcinoma of the lung. The study comprised 29 variables, including age, sex, smoking habit (SH), symptoms at diagnosis, the Karnofsky performance status (KPS), weight loss (WL), radiological findings, various disease extent parameters (DEP), CEA and TPA. Preliminary univariate analyses showed that 20 variables were survival-related. The Cox proportional hazards regression analysis selected stage of disease, KPS, TPA, WL, the existence of bone metastases, and SH as independent factors of prognosis (global chi-square: 122.40, P = 0.0000). A second multivariate analysis, performed with the same covariates but excluding DEP, revealed previous pulmonary diseases and CEA to be, in addition to KPS, TPA, SH, and WL the next most influential prognostic determinants. Also in squamous cell lung cancer, classifications based on the Cox's prediction equation may improve individual counseling and patient selection for therapeutic trials. In this malignancy, TPA shows an independent and strong prognostic significance while CEA shares informations of diverse other prognostic factors and seems to be less important.

摘要

相似文献

1
Carcinoembryonic antigen (CEA), tissue polypeptide antigen (TPA) and other prognostic indicators in squamous cell lung cancer.
Lung Cancer. 1993 Oct;10(1-2):21-33. doi: 10.1016/0169-5002(93)90306-i.
2
Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.血清C反应蛋白、癌胚抗原升高以及N2期病变是非小细胞肺癌预后不良的指标。
Asia Pac J Clin Oncol. 2015 Dec;11(4):e22-30. doi: 10.1111/ajco.12091. Epub 2014 May 30.
3
Prognostic value of the tissue polypeptide antigen in lung cancer.组织多肽抗原在肺癌中的预后价值。
Chest. 1992 May;101(5):1287-92. doi: 10.1378/chest.101.5.1287.
4
CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group.鳞状细胞肺癌患者及作为参照组的化工行业工人中的细胞角蛋白19片段(CYFRA 21-1)、组织多肽抗原(TPA-M)、组织多肽特异性抗原(TPS)、鳞状细胞癌抗原(SCC-Ag)和癌胚抗原(CEA)
Anticancer Res. 2000 Nov-Dec;20(6D):5035-40.
5
Prognostic value of serum tumor markers in patients with lung cancer.血清肿瘤标志物在肺癌患者中的预后价值。
Respiration. 2002;69(1):25-9. doi: 10.1159/000049366.
6
Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis.小细胞肺癌分期及预后的临床和血清学标志物。一项多变量分析。
Cancer. 1990 Aug 15;66(4):722-32. doi: 10.1002/1097-0142(19900815)66:4<722::aid-cncr2820660421>3.0.co;2-j.
7
Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix.肿瘤标志物癌胚抗原(CEA)、组织多肽抗原(TPA)和鳞状细胞癌抗原(SCC-Ag)在国际妇产科联盟(FIGO)低风险IB期和IIA期子宫颈鳞状细胞癌患者中的应用。
Gynecol Oncol. 2000 Jan;76(1):103-6. doi: 10.1006/gyno.1999.5665.
8
Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.组织多肽抗原(TPA)与鳞状细胞癌抗原(SCC-Ag)、癌胚抗原(CEA)及新蝶呤在子宫颈癌中的预后意义
Cancer Lett. 2008 Apr 18;262(2):183-9. doi: 10.1016/j.canlet.2007.12.005. Epub 2008 Jan 28.
9
Serum biomarkers of non-neuron-endocrine origin in small-cell lung cancer: a 16-year study on carcinoembryonic antigen, tissue polypeptide antigen and lactate dehydrogenase.
Lung Cancer. 2000 Oct;30(1):37-49. doi: 10.1016/s0169-5002(00)00123-9.
10
Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer.评估鳞状细胞癌抗原作为肺癌新标志物的作用。
Cancer. 1990 Apr 1;65(7):1552-6. doi: 10.1002/1097-0142(19900401)65:7<1552::aid-cncr2820650717>3.0.co;2-d.

引用本文的文献

1
History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.肺癌中传统血清生物标志物的历史、分子特征及临床重要性
Surg Today. 2017 Sep;47(9):1037-1059. doi: 10.1007/s00595-017-1477-y. Epub 2017 Feb 22.
2
Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers.早期非小细胞肺癌的预后和预测生物标志物:CTC 和血清/血浆标志物。
Transl Lung Cancer Res. 2013 Oct;2(5):382-97. doi: 10.3978/j.issn.2218-6751.2013.09.02.
3
Lung tumour markers in oncology practice: a study of TPA and CA125.
肿瘤学实践中的肺癌肿瘤标志物:组织多肽抗原(TPA)和癌抗原125(CA125)的研究
Br J Cancer. 2002 Nov 4;87(10):1112-8. doi: 10.1038/sj.bjc.6600577.